Education
About Us
Working with TipRanks
Follow Us
Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
Total Valuation
Parenteral Drugs (India) Limited has a market cap or net worth of $101.08M. The enterprise value is $1.18B.
Market Cap$101.08M
Enterprise Value$1.18B
Share Statistics
Parenteral Drugs (India) Limited has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Parenteral Drugs (India) Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.09
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee93.47K
Profits Per Employee-1.20M
Employee Count909
Asset Turnover0.02
Inventory Turnover5.32
Valuation Ratios
The current PE Ratio of Parenteral Drugs (India) Limited is -0.14. Parenteral Drugs (India) Limited’s PEG ratio is <0.01.
PE Ratio-0.14
PS Ratio―
PB Ratio-0.01
Price to Fair Value-0.01
Price to FCF-22.24
Price to Operating Cash Flow-22.24
PEG Ratio<0.01
Income Statement
In the last 12 months, Parenteral Drugs (India) Limited had revenue of 84.96M and earned -763.62M in profits. Earnings per share was -25.61.
Revenue84.96M
Gross Profit30.31M
Operating Income0.00
Pretax Income-1.09B
Net Income-763.62M
EBITDA372.69M
Earnings Per Share (EPS)-25.61
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share―
Dividends & Yields
Parenteral Drugs (India) Limited pays an annual dividend of $1.125, resulting in a dividend yield of ―
Dividend Per Share$1.125
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Parenteral Drugs (India) Limited upcoming earnings date is May 30, 2022, TBA (Confirmed).
Last Earnings DateFeb 14, 2022
Next Earnings DateMay 30, 2022
Ex-Dividend DateSep 13, 2010
Financial Position
Parenteral Drugs (India) Limited as a current ratio of 0.06, with Debt / Equity ratio of -13.01%
Current Ratio0.06
Quick Ratio0.06
Debt to Market Cap9.99
Net Debt to EBITDA2.88
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Parenteral Drugs (India) Limited has paid -327.64M in taxes.
Income Tax-327.64M
Effective Tax Rate0.30
Enterprise Valuation
Parenteral Drugs (India) Limited EV to EBITDA ratio is 3.16, with an EV/FCF ratio of -244.32.
EV to Sales13.88
EV to EBITDA3.16
EV to Free Cash Flow-244.32
EV to Operating Cash Flow-244.32
Balance Sheet
Parenteral Drugs (India) Limited has $1.00K in cash and marketable securities with ₹1.07B in debt, giving a net cash position of $1.07B billion.
Cash & Marketable Securities$1.00K
Total Debt₹1.07B
Net Cash$1.07B
Net Cash Per Share―
Tangible Book Value Per Share-$276.32
Margins
Gross margin is 35.67%, with operating margin of 0.00%, and net profit margin of -898.77%.
Gross Margin35.67%
Operating Margin0.00%
Pretax Margin-1284.39%
Net Profit Margin-898.77%
EBITDA Margin438.65%
EBIT Margin-33.89%
Analyst Forecast
The average price target for Parenteral Drugs (India) Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―